Dr. Reddy’s Laboratories has highlighted the significant influence of the Goods and Services Tax (GST) regime on India’s pharmaceutical industry, noting that while the framework has simplified compliance, it has also introduced structural challenges. The company emphasized that GST has reshaped pricing, supply chain dynamics, and input costs, forcing drug manufacturers to recalibrate business strategies.